2023-08-09 16:08:10 ET
- Illumina press release ( NASDAQ: ILMN ): Q2 Non-GAAP EPS of $0.32 beats by $0.30 .
- Revenue of $1.18B (+1.7% Y/Y) beats by $20M .
- Shipped 109 NovaSeq X instruments in Q2 2023; boosting our supply capacity to more than 390 instruments for fiscal year 2023.
- Now expect fiscal year 2023 consolidated revenue growth of approximately 1% from 2022, including Core Illumina revenue that is approximately flat with 2022 and GRAIL revenue still in the range of $90 million to $110 million
- Now expect GAAP diluted loss per share of $(2.08) to $(1.93) for fiscal year 2023
- Now expect non-GAAP diluted earnings per share of $0.75 to $0.90 for fiscal year 2023.
- Shares -5.44% .
For further details see:
Illumina Non-GAAP EPS of $0.32 beats by $0.30, revenue of $1.18B beats by $20M